US-based PhRMA has used its submission to the Office of the USTR 2023 Special 301 Report to call for Australia's inclusion in the agency's 'Watch List' and welcomed a possible first meeting of the government-to-government working group in 15 years. …
US-based industry wants Australia added to trade 'Watch List' over FTA breaches
February 6, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
Taking a stake is not the same as spectating investor risk and expecting a benefit
September 10, 2026 - - Latest News -
Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this
September 10, 2026 - - Latest News -
Melbourne oncologist takes the reins at Australia's private cancer physicians body
September 10, 2026 - -
Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence
September 10, 2026 - - Latest News -
Which is it? The two perspectives on patient input compounded by the lack of transparency
September 10, 2026 - - Latest News